Palouse Capital Management, Inc. Amgen Inc Transaction History

Palouse Capital Management, Inc.

$154 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 21, 2022	SELL	$224.46 - $253.15 $70,704 - $79,742	-315 Reduced 2.85%	10,757 $2.43 Million
Q2 2022 Jul 28, 2022	SELL	$230.71 - $256.74 $1.08 Million - $1.2 Million	-4,679 Reduced 29.71%	11,072 $2.69 Million
Q1 2022 Apr 21, 2022	SELL	$219.27 - $242.57 $43,196 - $47,786	-197 Reduced 1.24%	15,751 $3.81 Million
Q4 2021 Jan 25, 2022	SELL	$198.88 - $227.6 $45,941 - $52,575	-231 Reduced 1.43%	15,948 $3.59 Million
Q3 2021 Oct 21, 2021	SELL	$212.27 - $248.7 $98,281 - $115,148	-463 Reduced 2.78%	16,179 $3.44 Million
Q2 2021 Jul 28, 2021	SELL	$233.58 - $259.14 $17,752 - $19,694	-76 Reduced 0.45%	16,642 $4.06 Million
Q1 2021 May 11, 2021	SELL	$221.91 - $258.6 $77,002 - $89,734	-347 Reduced 2.03%	16,718 $4.16 Million
Q4 2020 Feb 03, 2021	SELL	$216.38 - $257.67 $392,513 - $467,413	-1,814 Reduced 9.61%	17,065 $3.92 Million
Q3 2020 Nov 02, 2020	SELL	$234.65 - $260.95 $983,652 - $1.09 Million	-4,192 Reduced 18.17%	18,879 $4.8 Million
Q2 2020 Aug 05, 2020	SELL	$197.81 - $242.74 $169,127 - $207,542	-855 Reduced 3.57%	23,071 $5.44 Million
Q1 2020 May 07, 2020	BUY	$182.24 - $241.7 $549,453 - $728,725	3,015 Added 14.42%	23,926 $4.85 Million
Q4 2019 Feb 07, 2020	SELL	$189.21 - $243.2 $345,875 - $444,569	-1,828 Reduced 8.04%	20,911 $5.04 Million
Q3 2019 Oct 31, 2019	BUY	$174.11 - $208.62 $5,397 - $6,467	31 Added 0.14%	22,739 $4.4 Million
Q2 2019 Aug 06, 2019	BUY	$166.7 - $195.41 $3.79 Million - $4.44 Million	22,708 New	22,708 $4.19 Million
Q3 2018 Oct 29, 2018	SELL	$185.29 - $208.89 $6.27 Million - $7.07 Million	-33,865 Closed	0 $0
Q2 2018 Jul 27, 2018	SELL	$166.05 - $186.51 $73,228 - $82,250	-441 Reduced 1.29%	33,865 $6.25 Million
Q1 2018 May 04, 2018	BUY	$169.43 - $198.0 $291,758 - $340,956	1,722 Added 5.28%	34,306 $5.85 Million
Q4 2017 Feb 05, 2018	SELL	$168.79 - $188.59 $56,038 - $62,611	-332 Reduced 1.01%	32,584 $5.67 Million
Q3 2017 Oct 30, 2017	BUY	$167.29 - $191.0 $5.51 Million - $6.29 Million	32,916	32,916 $6.14 Million

Others Institutions Holding AMGN

# of Institutions

3,075

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Palouse Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Palouse Capital Management, Inc. with notifications on news.

Account